Replies to post #183969 on Biotech Values

[IanFromSI]

When contacted by BNN ( a Canadian Financial news network), they advised that they couldn't justify the price that ACT has agreed to pay for it.

I don't believe they can make such a public statement and then legally go after the company.

[DewDiligence]

Agree with Ian—the bidding is over. AGN is a great company, but there’s a limit. I never thought the price would reach $219/sh, making this the third-largest healthcare merger of all time, based on the nominal deal value of $66B.